The Hong Kong Institute of Allergy acknowledges the following sponsors for their unrestricted educational grants which make it possible for HKIA to promote knowledge and treatment for those suffering from allergic diseases through its activities:
| Gold Sponsor
(HK$300,000 – $500,000 per year): |
|
 |
| |
|
|
| Silver
Sponsor (HK$100,000 – $299,999 per year): |
|
|
| |
|
|
|
|
| |
|
|
Sponsor
for e-Newsletter
(October 2015 Issue): |
|
 |
| |
|
|
| |
|
|
| |
|
|
8th Hong Kong Allergy Convention Sponsors:
A. Menarini Hong Kong Limited
AbbVie Limited
AstraZeneca Hong Kong Limited
Bristol-Myers Squibb Pharma (HK) Ltd.
Boehringer Ingelheim (HK) Ltd.
Celki Medical Company
Danone Nutricia Early Life Nutrition (HK) Ltd.
GlaxoSmithKline Ltd.
|
Hago Limited
Janssen, a division of Johnson & Johnson (HK) Ltd.
Medic-Pharm Technology (International) Limited
Mundipharma (HK) Ltd.
Nestle Hong Kong Ltd.
Novartis Pharmaceuticals (HK) Ltd.
Nutricia Clinical (HK) Limited
Pfizer Corporation Hong Kong Limited
|
R-Biopharm AG
Roche Hong Kong Limited
Takeda Pharmaceuticals (Hong Kong) Limited
Thermo Fisher Scientific (Hong Kong) Limited
Wei Lun Foundation Limited
Weijian Medical Company Limited
Wyeth Nutrition
Zenfields (HK) Ltd.
|
Notes:
- Unrestricted Educational grants for the Hong Kong Institute of Allergy ("the Institute") shall comply with all relevant aspects of codes of conduct of the sponsor and the Institute.
- Support of an educational grant is not a reward to favoured sponsors nor as an inducement to recommend, prescribe or purchase products or services.
- Propriety and independence of the Institute of Allergy will be ensured.
- Sponsors agree that it will first obtain the Institute's prior written consent before it identifies the Institute in any promotional material and statement, or otherwise uses the name of any member or staff of the Institute, or any trademark, service mark, trade name, or symbol of the Institute.
|
